Bladder Carcinoma
Bladder carcinoma is the second most common tumour disease of the urogenital tract. Cardinal symptoms may be a painless macro-haematuria, and also irritative micturition disorders. In addition to physical examination, diagnostics also include sonography, cystoscopy, and excretory urography.
Treatment / Therapy
Transurethral resection (TUR-B) is sufficient in superficial tumours. Depending on the size and grading of the tumour, instillation therapy, such as Mitomycin, can be undertaken as adjuvant treatment. For the detection of flat tumours (carcinoma in situ), a TUR-B should be performed with "photodynamic diagnostics". To this end, a fluorescent substrate is instilled into the bladder, which is absorbed by cells with a high substrate turnover.
If tumour growth is muscle invasive, the only curative option is a radical cystectomy. Depending on the patient's approval and age, for a urinary diversion an orthotopic bladder replacement (neoblase) or an ileum conduit may be called for.
At the metastasised stage, individualised treatment concepts will be implemented using chemotherapy.
Contact
Clinic and Polyclinic for Urology
OÄ Dr. Laura Hoppe
Clinic and Polyclinic for Urology
OA Dr. Maik Pechoel
Contact
Tamara Usichenko
Geschäftsbereich Patientenmanagement
Universitätsmedizin Greifswald
Fleischmannstr. 8
17475 Greifswald
Phone: +49 3834 86-5184
Mobil: +49 151 55459980
E-Mail: international.patientsmed.uni-greifswaldde